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Angiogenesis in autosomal-dominant polycystic kidney disease. nance imaging angiographic studies were utilized to diag-
Background. Autosomal-dominant polycystic kidney dis- nose ADPKD, and revealed separated and distorted
ease (ADPKD) is a genetic disorder that is responsible for large vessels displaced by the cyst growth. Using car-approximately 10% of all cases of end-stage renal disease
mine-colored gelatin, in 1929 Ritter and Baehr described(ESRD). It is characterized by the formation of epithelial cell
that the “interlobar and interlobulat arteries . . . [incysts, an increase in the extracellullar matrix, and vascular
alterations believed to be the result of compression by the ADPKD] largely lie in the cysts walls . . . [and that] in
cysts. Our recent observations demonstrated a rich vascular almost every one of the larger cysts there are numerous
network on the surface of the cysts, and thus, we postulated that arteries of various sizes which lie directly beneath theangiogenesis could be a factor in the progression of ADPKD.
lining epithelium” [4–7]. Compression of the tubules andMethods. Kidneys removed from patients with ADPKD
were studied using (1) angiographs, (2) immunostaining [factor vasculature by the cysts and effects of pressor substances
VIII-related antigen, vascular endothelial growth factor (VEGF), have been suspected to participate in the progression to
VEGF receptors 1 and 2 (VEGFR-1 and VEGFR-2), metallo- end-stage renal disease (ESRD) [8, 9]. Abnormalities in
proteinase-2 (MMP-2), and integrin v3], and (3) Western blot the anatomy of the renin-secreting cells were reportedanalysis and enzyme-linked immunosorbent assay. The expres-
by Graham and Lindop, who described that “renin con-sion of VEGF165 in ADPKD cells in culture was determined.
Results. There was (1) an extensive capillary network in the taining cells were . . . found in attenuated arteries in the
cyst wall of ADPKD kidneys, (2) morphological evidence of wall of cysts” and that “about half of the cells containing
vascular malformations, (3) expression of VEGF165 in cyst cells renin are situated in arteries” [10].of VEGFR-2 in endothelial cells and an absence of VEGFR-1
Inasmuch as the disease is characterized by the prolif-in endothelial cells, (4) secretion of VEGF165 by ADPKD cyst
eration of poorly differentiated epithelial cells and thecells in culture, and (5) coexpression of matrix MMP-2 and
integrin v3 in vessels from ADPKD. increase of the extracellullar matrix, it seems obvious
Conclusions. There is angiogenesis in ADPKD. This process that the blood supply needs to be adequate to provide
may be necessary for cyst cells to grow and may be responsible
oxygenation and nutrients in proportion to the expansionfor increased vascular permeability facilitating fluid secretion
of the epithelium and interstitium. Early observations ininto the cysts. Neovascularization may result in the formation
of aneurysms responsible for the renal bleeding in this disease. our laboratory indicated the existence of a rich vascular
network on the surface of cysts from ADPKD. We postu-
lated that angiogenesis could be a factor in the progres-
Autosomal-dominant polycystic kidney disease sion of ADPKD. Whereas angiogenesis is fundamental
ADPKD) is a frequent genetic disorder responsible for to the processes of reproduction, development and repair
approximately 10% of all cases of end-stage renal disease [11, 12], it also plays a role in pathological processes,
(ESRD) [1–3]. Little information exists on the distribu- including cancer. Angiogenesis is stimulated by several
tion and characteristics of the microcirculation of the growth factors, including vascular endothelial growth
kidney in ADPKD. Before the advent of renal ultra- factor (VEGF) [13–16]. Early in the process of angiogen-
sound, computed tomography scans and magnetic reso- esis, the endothelial cell basement membrane and sur-
rounding collagen and other matrix proteins are de-
graded by matrix metalloproteinases, and the capillaryKey words: vascular endothelial growth factor, inherited kidney dis-
ease, cysts, genetic disorder, progressive renal disease, KDR, MMP-2. basement membrane is disrupted, allowing migration of
the endothelial cells from preexisting vessels and subse-Received for publication May 10, 2000
quent proliferation [13, 17]. Metalloproteinases bind toand in revised form December 5, 2000
Accepted for publication January 25, 2001 cell adhesion molecules such as integrin v3, which are
induced by angiogenic factors. In the normal adult kid- 2001 by the International Society of Nephrology
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ney, constitutive expression of VEGF and VEGF recep- software (OIS, Sacramento, CA, USA) and stored for
differed analysis.tors is confined to the glomerulus (podocytes and capil-
For fresh preparations, cyst walls were cut free,laries, respectively) and some collecting ducts and
stretched on glass slides, covered with 1 mm cover slips,peritubular capillaries [18].
and observed immediately using a Nikon microscopeOur current study reports (1) the existence of an exten-
with 100 to 200 magnification. Microphotographssive capillary network in the cyst wall of ADPKD kid-
were taken with a Nikon camera.neys removed from patients in renal failure (ESRD), (2)
The appearance of ESRD-ADPKD kidneys wasmorphological evidence for vascular malformation, (3)
rather uniform. Enlarged kidneys measuring up to 30 bythe expression of the VEGF in cyst cells and of VEGF
20 by 18 cm had their surfaces covered by randomlyreceptor-2 in cyst cells and vessels, (4) the secretion of
distributed cysts of different sizes that also were presentVEGF by ADPKD cells in culture, and (5) the coexpres-
through the mass of the kidney. The cysts containedsion of matrix metalloproteinase-2 (MMP-2) and of in-
clear or dark fluid, the latter from past hemorrhages.tegrin v3 in vessels from ADPKD. Taken together,
Randomly taken samples for histopathology were pro-these findings are indicative of angiogenesis in ADPKD,
vided by pathologists at the University of Texas Medicala process that may be necessary for cyst cells to grow as
Branch and other medical centers. The samples corre-well as being responsible for increased vascular perme-
sponded to areas with moderately sized cysts, and theability—facilitating fluid secretion into the cysts—and a
intervening areas were shown to contain some normal-likely cause of the formation of aneurysms and renal
sized tubules and more frequently small cystic tubules.bleeding found in this disease.
In those areas, the classic description of interstitial fibro-
sis and coexistance with some preserved glomeruli was
METHODS confirmed. Hemorrhagic cysts were not studied.
Samples from different areas of the kidney were frozenTen kidneys surgically removed because of medical
embedded in Tissue Freezing Medium (TBS; Trian-indications from patients with ESRD secondary to
gle Biomedical Sciences, Durham, NC, USA) or fixedADPKD, donated for research to the Polycystic Kidney
in 4% paraformaldehyde and embedded in paraffin (t Research Foundation, were used. Four additional kidney
65C). Sections were placed on poly-l-lysine–treatedpreparations were available from the archives of the
slides. Paraffin blocks were cut at 3 to 4 m thicknessDepartment of Pathology, and new sections were ob-
and dried overnight at 40C. Paraffin was removed, andtained for light microscopy and immunostaining. The
the sections were rehydrated. For negative controls, themean age ( SD) of the patients at the time of kidney
primary antibody was omitted. Positive controls for fac-removal was 55.2 4.1 years. Of the 14 patients (6 males
tor VIII-related antigen were slides from normal kidneyand 8 females), 12 were white and 2 were Hispanic. Nine
tissue, and for VEGF and receptors, positive controlswere on dialysis at the time of transplant, and five had
were slides from breast cancer tissues. Staining for factor
a previous transplant and were receiving immunosup-
VIII-related antigen was performed using mouse anti-
pression. Two patients had hypertension. The kidneys human monoclonal antibody (Zymed Laboratories, Inc.,
were removed for medical reasons; the investigators South San Francisco, CA, USA) and was prediluted and
were not involved in the decision making conducive to used as per the manufacturer’s recommendations. Sec-
surgery. tions were selected from hematoxylin and eosin-stained
Some kidneys were perfused immediately after re- slices. An avidin-biotin peroxidase conjugate protocol
moval with lactate Ringer’s solution containing heparin was used. The chromogene was diaminobenzidine (DAB).
or with cold storage solution (ViaSpan; DuPont, Merck Staining for VEGF protein and VEGF-receptors 1 and
Pharmaceutical Co., Wilmington, DE, USA) and deliv- 2 (VEGFR-1 or flt-1 and VEGFR-2 or flk1/KDR) was
ered to our laboratory in wet ice. In preliminary experi- performed in sections contiguous to the ones studied for
ments, a branch of the renal artery was canulated and the factor VIII-related antigen. The antibodies used were as
tissue was perfused with a lactate-buffered physiological follows: anti-VEGF monoclonal antibody (NeoMarkers,
solution (pH 7.4, at 4C to 10C) also containing 50 g/L of Union City, CA, USA), which recognizes human iso-
Pentafraction (DuPont), adenosine 1.3 g/L, allopurinol forms of VEGF, including soluble proteins; specific anti-
0.136 g/L, and glutathione 0.922 g/L. The perfusion rate human VEGFR-1 monoclonal antibody (Flt-1 receptor),
was 1000 mL/hour, and the venous effluent was dis- and specific anti-human VEGFR-2 (KDR) monoclonal
carded. Angiograms were obtained after injection of Hy- antibody (Sigma-Aldrich, St. Louis, MO, USA). The pro-
paque and Fluorescein. For the latter, the kidney was cedure was similar to the one described for studies of
positioned in front of a Topcon-50 retina camera with factor VIII-related antigen staining. Images from immu-
filters for fluorescence measurements. Images were cap- nocytochemistry were acquired using a Nikon micro-
scope model Eclipse E800 (Nikon, Inc., Melville, NY,tured by an OIS digital computer using its proprietary
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USA) and a digital camera (Nikon Coolpix 950), and (ITES, Sigma-Aldrich, St. Louis, MO, USA), and non-
essential amino acids [22]. Passages 1 and 2 were used.were saved and stored. Image processing and analysis
was performed on a Dell Optiplex GX1 computer
Western blot analysis of cell culture lysates forequipped with image processing software (Adobe Pho-
detection of VEGFtoshop; Adobe Systems, Mountain View, CA, USA) us-
Cells were lyzed in lysis buffer (20 mmol/L Tris, 150ing the UTHSCSA Image Tool program (developed at
NaCl, 1 mmol/L phenylmethyl sulfonylfluoride (PMSF),the University of Texas Health Science Center at San
and 0.25% NP-40). Equal amounts of protein (200 g)Antonio, TX, USA by Wilcox et al and available from the
were loaded and separated by sodium dodecyl sulfate-Internet at http://uthscsa.edu/dig/itdesc.html) [19]. This
polyacrylamide gel electrophoresis (SDS-PAGE; 4 andprocess was similar to the reported by others [20]. In
20% Tris-Glycine gels; Novex, San Diego, CA, USA)three different sections for each condition, the image
and subsequently transferred to nitrocellulose mem-was divided in quadrants (numbered 1 through 4 and
branes (Hybond ECL; Amersham Pharmacia Biotech.,sequentially analyzed: picture 1, quadrant 1; picture 2,
Piscataway, NJ, USA). Blots were probed with a specificquadrant 2, etc.) determining the pixel value of cyto-
monoclonal antibody recognizing VEGF165 [VGEF Ab-4plasm areas (in a scale of 0 to 255) of cyst cells, endothe-
(BFDD31) 1:200 dilution; NeoMarkers, Inc.], followed
lial cells, or interstitial areas of comparative sizes. Nuclei by horseradish peroxidase-conjugated anti-mouse IgG
were excluded from analysis. antibody diluted 1:4000 (Amersham Pharmacia Bio-
To demonstrate colocalization for MMP-2 and integ- tech.). The detection of specific signals was performed
rin, v3 monoclonal antibodies against MMP-2 (goat, using the chemoluminescent substrate for detection of
anti-human) and fluorescein-conjugated integrin v3 horseradish peroxidase (SuperSignal West Pico Chemo-
(mouse, anti-human; Santa Cruz Biotechnology, Inc., luminescence Substrate; Pierce, Rockford, IL, USA). Re-
Santa Cruz, CA, USA) were used. The secondary anti- combinant VEGF165 protein (2.5 ng) served as a positive
body was anti-goat TRITC IgG1 (Sigma-Aldrich). Areas control (Ab-4; NeoMarkers). Ab-4 shows a single band
of colocalization appear yellow. Fluorescence was as- at19 kD. Protein from cultured human proximal tubule
sessed with a Nikon microscope Model Eclipse E800 cells, expecting to have low or no expression of VEGF,
(Nikon Inc.). Images were obtained using a Dage Single and from MCF-7 cells (human breast cancer cell line)
one-half inch cooled CCD camera (Advanced Scientific, was also used. Band intensities were quantitated by den-
Chamette, LA, USA) and processed with the Meta- sitometry (ImageQuant; Molecular Dynamics, Sunny-
morph Imaging System (Universal Imaging Corp., West vale, CA, USA).
Chester, PA, USA).
Anti-VEGF enzyme-linked immunosorbent assay
Cell cultures Vascular endothelial growth factor released to the cul-
ture medium was measured using anti-human-VEGFAutosomal-dominant polycystic kidney disease cells
antibody as the capture antibody (AF-293-NA) in combi-were isolated from ADPKD cysts from kidneys obtained
nation with a biotinylated VEGF affinity-purified poly-after nephrectomy and cultured in 5% CO2/95% air at
clonal detection antibody (BAF293; R&D Systems, Inc.,37C in Click-RPMI media [21], buffered with 10 mmol/L
Minneapolis, MN, USA) as per the manufacturer’s in-N-2-hydroxyethylpiperazine n-2-ethanesulfonic acid
structions. ADPKD cells and MCF-7 cells (human breast(HEPES), and supplemented with 1% fetal bovine se-
cancer cell line) were grown in 25 cm2 culture flasksrum (FBS), human transferrin (5 mg/mL), hydrocorti-
(Biocoat; Becton Dickinson Labware, Bedford, MA,sone 50 nmol/L–dexamethasone 5 nmol/L, insulin 5
USA) to confluence. The medium was removed. Cellsg/mL, and triiodothyronine 5 pmol/L (GIBCO BRL,
were washed three times with PBS and incubated forLife Technologies Inc., Rockville, MD, USA). Subcul-
eight hours in culture medium, as described previouslytures were obtained after confluence and passages 1
in this article. Some ADPKD cells were incubated for
through 3 were used. MCF-7 cells (human breast cancer 8 or 72 hours in an atmosphere of 90% N2/5% O2/5%cell line) were grown in improved minimum essential CO2. At the end of the incubation period, the condi-medium (IMEM) Eagle’s (Richter’s medium) (GIBCO tioned media were removed, centrifuged at 3000 r.p.m.
BRL) also containing 10% FBS and penicillin/strepto- for 10 minutes, and stored at 	20C until the time of
mycin. Proximal tubule cells, obtained from normal areas analysis. Triplicates samples were analyzed. The VEGF
of kidneys removed because of cancer, were isolated as released was expressed per mg of cell protein. VEGF
previously described [22] and cultured in 1:1 Dulbecco’s was not detectable in the culture medium used.
modified Eagle’s medium (DMEM)/F-12 media supple-
Protein measurementsmented with 25 mmol/L HEPES; 21.5 mmol/L H2CO3;
4 mmol/L l-glutamine; 10 mg/L insulin, 5.5 mg/L trans- Protein was measured by colorimetry using the Bio-
Rad DC Protein Assay Kit (Bio-Rad, Hercules, CA,ferrin, 2 mg/L ethanolamine, 5 g/L sodium selenite
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Fig. 1. (A) Radiopaque medium angiogram
in a ADPKD kidney perfused in vitro (4C,
with preservation solution at 1000 mL/h) 15
(left panel), 30 (center panel), and 60 seconds
(right panel) after bolus injection of 50 mL of
Hypaque 60 in the upper pole renal artery.
(Left panel) Note the stretching and displace-
ment of large vessels. (Central panel) Note
the vascularization around the cysts and filling
of aneurysmatic dilatations (arrows). (Right
panel) Note the tuft-like vessels with peripher-
ally broader branches, rather than the normal
tapering (arrows). (B) Fluorescent angiogram
of the surface of the same kidney (perfused
as described for A) injected with 1 mL of
Fluorescein shows vascularization around
the cysts, abnormal vessels, and filling of lacu-
nar spaces.
USA) adapted to cuvettes. Bovine serum albumin (BSA) Small-vessel network found in the walls
was used as the standard. Absorbance was measured of ADPKD cysts
at 750 nm using a Beckman DU-62 spectrophotometer As shown in Figure 2 (insert), the cyst walls are highly
(Beckman, Fullerton, CA, USA). vascular with randomly distributed tortuous vessels. Mi-
croscopic examination of tissues stained for factor VIII-Statistics
related antigen demonstrated that the cyst walls con-
Results are reported as mean SEM unless otherwise
tained fibrovascular connective tissue. There was intense
stated. Data were analyzed using Student t test for un-
proliferation of vasculature, predominantly composedpaired data or population analysis, as required by the ex-
of capillaries of varying caliber. In some places, theyperimental design. P 0.05 was considered significant [23].
assumed angiomatous configurations, resembling cav-
ernous angiomata (Fig. 2A). The increased vascularity
RESULTS was also appreciated in the renal interstitial parenchyma
away from the cysts, apparently indicating angiomal-Angiography suggests angiogenesis around the cysts
formations involving the entire kidney in ADPKD (Fig.Angiography performed in a nephrectomized ADPKD
2A). Similar architecture and distribution were found inkidney demonstrated the presence of aneurysms and of
all ADPKD specimens studied.broad tuft-like vessels as well as extravasation of the
In other areas, in the interstitium (Fig. 2B), and espe-contrast medium1 (Fig. 1A) [24]. In the same kidney,
fluorescein was injected in the upper pole artery, and an cially beneath the cyst epithelium (Fig. 2C), the vessels
angiogram was performed. As shown in Figure 1B, there assumed a “corkscrew” pattern. Ingrowths of neovascu-
is a rich network of vessels in the cyst wall. The vascula- larization were also seen into the lamina propria of the
ture of the cyst wall includes spiral shaped, tortuous, intraluminal papilliferous projections of the cyst epithe-
and dilated vessels. These findings, similar to the ones lium (Fig. 2D). By comparison, in the normal kidney, the
reported in the diabetic retina [25], are suggestive of arterial circulation had a quite regular pattern showing a
angiogenesis. progressive tapering of the caliber of the arterial vessels
toward the kidney periphery. The network of capillaries
1 Angiographs showed extravasation of the contrast, but this observa- was in close contact with the epithelial basement mem-
tion has to be taken with caution since the kidney studied was subjected brane and also exhibited a notable regularity in diameterto cold ischemia and perfusion with preservation solution, factors that
have been reported to alter the vascular permeability. at any given cross section of the kidney [26].
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Fig. 3. (A) Immunohistochemistry for VEGF is positive in the epithe-
lial cyst cells (brown color, Nikon, 400). (B) Negative control (Nikon,
400).
Fig. 4. Immunostaining for VEGF, VEGFR-2, and VEGFR-1 (left,
central, and right upper panels, respectively) in areas of relatively pre-
served morphology. Glomeruli and remnant tubules are recognized.
(Upper left) Staining for VEGF seen in some tubule cells (arrow).
(Center) Staining for VEGFR-2 seen in interstitial areas with increased
matrix, at high power corresponding to vasculature (short arrow, at the
right), in some cells of the remnant glomerulus cells (long arrow) and
in remnant tubule cells (narrow, short arrow at the left). (Right) Staining
for VEGFR-1 seen in remnant tubule cells (arrow). No staining of
interstitial structures or of the glomerulus (in the right upper corner)
is seen. Lower panels are the negative controls. Left for VEGF, center
for VEGFR-2, and right for VEGFR-1 (Nikon, 100).
VEGF is expressed in cyst cells
Vascular endothelial growth factor was demonstrated
in cyst cells by immunohistochemistry. Expression levels
were variable but observed in the cells of both fully
developed cysts and small tubular dilations (Fig. 3A).Fig. 2. Vascular network in the wall of ADPKD cysts. (Insert) Freshly
The negative control is shown in Figure 3B. Image analy-mounted cyst wall without staining observed in an inverted Nikon
microscope (200). Note the capillaries and small vessels containing sis by pixel value in a scale of 0 to 255 (Methods section)
red cells. (A) Microscopic examination of ADPKD kidney sections was 104  2 in cytosol areas of cyst cells (N
 185, rangestained for factor VIII-related antigen. The cyst walls are composed of
51 to 195) versus 51  2 (N 
 63, 19 to 85) in thefibrovascular connective tissue. There are numerous of capillaries of
variable caliber, some of them assuming angiomatous configurations interstitium (P  0.0001). The negative control pixel
resembling cavernous angiomata (arrows, Nikon 100). (B) Interstitial value was 36  2 for cyst cells (N 
 127, P  0.0001,area demonstrating dilated vessels in a “corkscrew” pattern. Nikon
positive cyst cells vs. cyst cells negative control) and 33200. (C) Microcirculation beneath a renal cyst shows the “corkscrew”
characteristic vasculature seen also in interstitial areas (Nikon 40). 2 for intertitium (N
 127, P 0.0001 intertitium positive
(D) Factor VIII-related antigen staining demonstrating ingrowth of vs. negative control). Thus, the antibody recognized anvasculature into the lamina propria of the intraluminal papilliferous
epitope in the cyst cells as well as in some areas of theprojections of the cyst epithelium (Nikon 400).
interstitium, although at lower levels. Figure 4 (left upper
panel) shows staining for VEGF in intervening areas of
Bello-Reuss et al: Angiogenesis in ADPKD42
Fig. 5. Immunostaining demonstrates the expression of VEGFR-2
(KDR) in small vessels in the interstitium of a cyst. The narrow cyst
epithelial cells (arrow at the top) do not express VEGFR-2 (Nikon
400).
more preserved morphology, demonstrating expression
of VEGF protein in the cells of some enlarged tubules.
A glomerulus on the field was not stained. A negative
control is shown in the lower panel.
VEGF-receptors 1 and 2 expression
in ADPKD kidney Fig. 6. (A) Determination of VEGF165 expression by Western blot anal-
ysis with the specific monoclonal antibody VEGFab-4. Lane 1, controlIn adult kidney, expression of VEGF-receptors 1 and
recombinant VEGF165. Lane 2, protein from human proximal tubule2 (VEGFR-1 and VEGFR-2) has been reported in glo- cells in culture (HPT). Lanes 3, 5, and 6, protein from three different
meruli endothelial cells by in situ hybridization [18]. In ADPKD cyst cell cultures: PKD(1), PKD(2), and PKD(3). Lane 4,
protein from MCF-7 cells (a human cancer cell line). (B) VEGF165 intumors, it has been reported in endothelial and in cancer
pg/mg protein in the conditioned medium of ADPKD cyst cells cultured
cells [17]. Immunostaining for VEGFR-1 and VEGFR-2 in 20% or 5% O2 for 8 or 72 hours (Methods section). The release of
VEGF165 increased after incubation in low oxygen for 72 hours. Symbolswas positive in ADPKD. Staining for VEGFR-1 was
are: () ADPKD, 20% O2 for 8 hours; () ADPKD, 5% O2 for 8found in the cells of small cystic tubules and in remnant
hours; ( ) ADPKD, 20% O2 for 72 hours; ( ) ADPKD 5% O2 fortubules, as shown in Fig. 4 (upper right panel); no staining 72 hours; ( ) MCF/7, 20% O2 for 8 hours; ( ) MCF/7, 5% O2 for 8
hours. *P 
 0.014, N 
 6.was found in the glomeruli or interstitial vasculature.
Image analysis showed a pixel value (scale 0 to 255) of
101  2 (range 30 to 221) in cystic tubules and tubule
cells (N 
 292), 38  1 in the interstitium (N 
 155, 4
ADPKD cell cultures produce soluble VEGFto 85, P  0.0001 cyst vs. intertitium), and 31  2 in
Western blot analysis. VGEF-soluble protein was de-endothelial cells (N 
 52, 9 to 72, P  0.0001 cyst cells
tected as a single band of approximately 19 kD. Bandsvs. endothelial cells). The negative control pixel values
shown in lane 1 of Figure 6A correspond to the positivewere 32  2 (N 
 100), 35  2 (N 
 102), and 33  2
control (recombinant VEGF165); lanes 3, 5, and 6 corre-(N 
 50) for cyst cells, intertitium, and endothelial cells,
spond to three different isolates of protein from ADPKDrespectively (Discussion section).
cells; and bands in lane 4 loaded with lysate from MCF-7Vascular endothelial growth factor receptor-2 (also
cells (a cancer cell line). A lower expression was found inknown as KDR) was expressed in endothelial cells of
lane 2 corresponding to cultured human proximal tubulesmall vessels surrounding cysts (Fig. 5), as well as in some
cells. Densitometric analysis of the specific bands showedglomerular cells and remnant tubules (Fig. 4, central
that the relative expression of VEGF normalized to theupper panel). The negative control is shown in Figure 4
recombinant VEGF165 control was 30.5  10.3 for proxi-(lower-central panel). Image analysis showed a pixel value
mal tubule (PT) cells, 82.4  11.5 for ADPKD cells, and(scale 0 to 255) of 145  4 for endothelial cells (N 
 119,
56.2  11.5 for MCF-7 cells (N 
 3).range 46 to 224) versus 32  2 for interstitium (N 
 62,
ELISA test demonstrates soluble VEGF in the culture0 to 66, P  0.0001), and 40  3 for cyst cells (N 
 98,
medium from ADPKD cells. To confirm the up-regula-0 to 99, P  00001 cyst vs. endothelial cells, P  0.0001
tion of VEGF by hypoxia, the amount of VEGF releasedcyst cells vs. interstitium). The negative control pixel
to the culture medium was measured by the ELISAvalues were 38  3 (N 
 98), 33  2 (N 
 105), and
method. VEGF release was significantly higher in the33 3 (N
 50) for cyst cells, intertitium, and endothelial
cells, respectively. medium from cells hypoxic for 72 hours (10,879  1745
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Fig. 7. (A and B) Immunofluorescence photo-
micrographs of pericystic interstitial capillaries
stained with FITC-anti-integrin v3 antibody
(green). (C and D) RITC-anti-MMP-2 immu-
nostaining (red). (E and F) Colocalization of
FITC-anti-integrin v3 and anti-MMP-2 anti-
bodies (yellow), indicating the coexpression
in the lining of endothelial cells. (G and H)
The corresponding fields to A and B (sections
are serial, a few micrometers away) identifying
the capillaries with antibody directed against
Factor VIII-related antigen.
and 61,1321 12,145 pg/mg protein for control and hyp- vasculature is prominent in the cyst walls and that the
oxia, respectively, N 
 6, P 
 0.014). VEGF was also vessels have an abnormal appearance (see 1 on p. 40).
detected in the medium from MCF-7 cells (a breast can- Staining for factor VIII-related antigen demonstrated
cer cell line) in amounts not different from those mea- dilated vessels of abnormal morphology that in some
sured in the supernatant from ADPKD cells (8163  places assume angiomatous configuration and extend into
1235 pg/8 h/mg protein, N
 3; P
NS; Fig. 6B). VEGF165 the lamina propria of the papilliferous grows into the
was undetectable in the unconditioned media (data not cysts. Spiral and dilated vessels were observed in areas
shown). without evidence of inflammation but with interstitial
Metalloproteinase-2 and integrin v3 colocalize in kid- fibrosis, indicating that the abnormalities of the vascula-
neys from ADPKD. The expression of the vitronectin ture are not limited to the areas of the cyst expansion.
receptor integrin v3 and MMP-2 were studied in There is no other possible explanation for the extension
ADPKD kidney sections. Both MMP-2 and integrin v3 of vasculature into the papilliferous growths that neofor-
were functionally associated in the surface of angiogenic mation of capillaries.
blood vessels [27]. It is believed that this cooperative The VEGF and VEGFR-2 (KDR) in the normal adult
interaction facilitates the invasive behavior of endothe- kidney are expressed in the visceral epithelial cells and
lial cells [27]. We found that there was coexpression of in the endothelia of glomeruli, respectively. The adult
MMP-2 and integrin v3 in the vessels of polycystic kidney also exhibits a weak expression of VEGF in the
kidneys, in areas around the cysts, and in the expanded collecting duct and of VEGFR-2 in the surrounding cap-
matrix (Fig. 7).2 illaries [18]. The pattern of expression in ADPKD kidney
was quite different: The epithelial cells of some cysts
and enlarged tubules in more preserved areas expressDISCUSSION
VEGF, and some capillaries around the cysts express
Our study examined the vasculature of kidneys re- VEGFR-2 (KDR) receptor, the receptor involved in
moved from patients with ADPKD and observed a rich neovascularization [28]. Expression of VEGFR-2 in
network of vessels in the cyst walls. Although the renal some glomeruli was noted. The significance of the irregu-
circulation appears reduced in the angiographs, because lar staining of some cyst cells and in some remnant tu-
of the fluid accumulated in the cysts and to the decrease bules for VEGFR-1 is unclear. The anti–VEGFR-1 anti-
in the mass of functional tissue, the cyst wall has a well- body is believed to be a specific monoclonal antibody of
developed vascular network. Angiograms with radi-
human VEGFR-1. It reacts specifically with VEGFR-1 of
opaque medium and with fluorescein indicate that the
human origin and does not cross-react with VEGFR-2 or
other tyrosine kinases. The monoclonal anti–VEGFR-2
is derived from a KDR-2 hybridoma; purified recombi-2 Sections were believed to be from normal areas from two kidneys
removed because of cancer showed staining for MMP-2 and integrin nant human extracellular VEGFR-2 was the immuno-
v3, but no areas of colocalization were found. The influence of soluble gen. The antibody is considered specific for humanfactors from the cancer cells and their vasculature in the integrin v3
and MMP-2 expression could not be determined. VEGFR-2. It does not recognize VEGFR-1 or other
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VEGF receptors or platelet-derived growth factor recep- induces them to proliferate (Methods section). Evidence
of the importance of this VEGF and VEGFR-2 interac-tor. Thus, the reactivity found in cyst cells could repre-
sent a true abnormality of the ADPKD cells that will tion to induce the VEGF biological response is abundant
in the literature, as well as evidence for VEGF’s role inrequire further investigation, like the expression of a
related protein. Expression of both receptors has been pathological angiogenesis [reviewed in 28]. In this context,
our findings demonstrate the presence of a permissivedescribed in nonvascular cells of neural cells of the hyp-
oxic retina, a finding taken to suggest an autocrine role condition for vascular remodeling and proliferation.
The cellular invasion by endothelial cells—be they inof these receptors in the effect of VEGF [29]. Taken
together, these experiments demonstrate that the condi- cancerous growths, inflammatory processes, or during
repair—requires cell adhesion and migration mediatedtions necessary to stimulate angiogenesis in the vicinity
of the cysts are present in ADPKD kidneys.3 by integrins and matrix-degrading enzymes. In particu-
lar, the MMP-2 and the adhesion protein integrin v3Vascular endothelial growth factor is also known as
vascular permeability factor (VPF) and is recognized have been shown to colocalize to the surface of invasive
endothelial cells [32]. Our studies provide evidence thatas potent agent—some 50,000 times more potent than
histamine—that increases capillary permeability [30, 31]. integrin v3 localizes with MMP-2 on the endothelial
surface of ADPKD blood vessels, a finding that supportsOur findings suggest that cyst development is associated
with local enhancement of the vasculature, which in turn the idea that both cell migration and the matrix degrada-
tion necessary for invasion by the neovasculature occurmay facilitate or promote fluid secretion into the cysts.
Furthermore, we propose that the molecular mechanism in ADPKD. MMP-2 has been demonstrated by immuno-
histochemistry in the septa between cysts and associatedof this process involve secretion of VEGF-stimulating
neovascularization that would allow for the growth of interstitium in kidneys of the C-57BL/6 J-cpk mice, a
mouse model for autosomal recessive polycystic kidneythe cyst, as a tumor, with a balanced blood supply. This
process necessarily should differ from the neovasculari- disease (ARPKD). Thus, MMP-2 could act as a facilita-
tor for the degradation of the interstitial matrix, allowingzation of malignancy, and could be triggered by hypoxia
of the tubule cells and of the cysts as they expand. The for cyst expansion [33].
Recently, it has been reported that mouse homozygousprocess is unlikely to be synchronized to the whole kid-
ney but would be present—at a given time—only in areas for Pkd1(L) mutant allele exhibit vascular fragility and
were not viable after day 15.5, suggesting that poly-of active cyst growth.
Alternative gene splicing of a single VEGF gene can cystin-1 may have a functional role in maintaining vascu-
lar integrity during angiogenesis [34]. The relevance ofgenerate four different molecular species, of which
VEGF165 is the predominant form found in a variety of this finding to the development of vascular abnormalities
in ADPKD is yet to be determined.normal and transformed cells. VEGF165 is secreted but
a fraction remains bound to cell membrane or to the In summary, the cysts in ADPKD are well vascu-
larized, the vessels exhibit several malformations includ-extracellullar matrix, from where it can be released by
heparin [reviewed in 17, 28]. Additional experiments ing aneurysmal and spiral forms, that the cyst cells ex-
press VEGF, and cyst cells in culture produce the solublewere performed to determine whether a soluble form of
VEGF was present in ADPKD cells grown in culture form. The VEGFR-2 (KDR) is present in some of the
vessels of ADPKD, and there is colocalization of MMP-2and if the soluble form was secreted to the culture me-
dium. Our Western blot experiments and ELISA deter- and integrin v3. All of these findings indicate that the
angiogenesis process occurs in ADPKD. The presenceminations both demonstrate VEGF165 in ADPKD cells
and supernatant (conditioned medium) of ADPKD cell of VEGF, also known as VPF, may be important in
increasing capillary permeability and favoring fluid trans-cultures. We also found that VEGF secretion increased
during hypoxia, one of the conditions that has been re- port into the cysts. In addition, inhibition of angiogenesis
may open new avenues for treating the disease [11, 17,ported to up-regulate VEGF expression caused by tran-
scriptional activation and increased mRNA stability [28]. 28]. As a whole, our findings can be taken as complemen-
tary to the pathological changes, recognized as beingAccordingly, we submit that the cyst cells produce VEGF
that is secreted into the interstitium and is available to of a tumorous nature, occurring in epithelial cells and
culminating in cyst formation and expansion [35–37].bind to the VEGFR-2 present in endothelial cells and
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